Articles tagged "Kidney transplantation"

2017 American Transplant Congress
Clinical Outcomes of ABO and HLA Incompatible Kidney Transplantation – Nationwide Cohort Study.
E. Ko,^1,2 J. Yu,^1,2 C. Yang,^1,2 B. Chung,^1,2 Korean Organ Transplantation Registry (KOTRY).
¹Transplantation Research Center, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea; ²Division of Nephrology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
Background This is a nationwide cohort study to investigate the impact of anti-A/B antibody or donor specific anti-HLA antibody (HLA-DSA) on the clinical outcomes in…
2017 American Transplant Congress
Risk Factors of Treatment Failure in Antibody Mediated Rejection.
V. Pernin,¹ I. Szwarc,¹ T. Kanouni,² V. Garrigue,¹ J. Serre,¹ S. Delmas,¹ G. Mourad,¹ M. Le Quintrec.¹
¹Department of Nephrology, Dialysis and Transplantation, CHU Lapeyronie, Montpellier, France; ²Department of Hematology, CHU St ELoi, Montpellier, France
Background: Antibody-mediated rejection (AMR) is recognized as the major cause of kidney allograft loss. Despite an aggressive treatment, prognosis is usually poor. The aim of…
2017 American Transplant Congress
Banff 2013 Classification of Renal Allograft Pathology Is Superior to Banff 2007 in Detecting and Managing Milder and Earlier Cases of Antibody-Mediated Rejection.
J. Hassler,¹ V. Ariyamuthu,² A. Hendricks,¹ B. Tanriover,² J. Torrealba.¹
¹Pathology, University of Texas Southwestern Medical Center, Dallas, TX; ²Medicine, Nephrology, University of Texas Southwestern Medical Center, Dallas, TX
The 2013 Banff meeting updated the requirements for the diagnosis of acute/active antibody-mediated rejection (AAMR) in kidney allografts. There has been speculation that the changes…
2017 American Transplant Congress
An OPO Offer Acceptance Report for Hard-to-Place Kidneys.
A. Wey, N. Salkowski, B. Kasiske, A. Israni, J. Snyder.
Scientific Registry of Transplant Recipients, Minneapolis, MN
Transplant program offer acceptance behavior varies substantially for kidneys after 100 previous offers (i.e., “hard-to-place offers”). An organ procurement organization (OPO) offer acceptance report could…
2017 American Transplant Congress
Correlation of Donor Clinical and Histopathological Characteristics with Graft Function in Kidney Transplant Recipients.
M. Zachariah,¹ C. Yip,¹ M. Zachariah, I. Mallawaarachchi,² A. Dweivedi,² S. Patel,⁴ A. Gundroo,¹ J. Tomaszewski,¹ L. Lin,¹ C. Shirley.¹
¹Medicine, SUNY at Buffalo, Buffalo, NY; ²Biostatistics and Epidemiology, Texas Tech University, El Paso, TX; ³Pathology, SUNY at Buffalo, Buffalo, NY; ⁴Surgery, SUNY at Buffalo, Buffalo, NY
Background: There is lack of consensus in the perceived accuracy of frozen biopsy interpretation. Interobserver variability in assessment of pre-implantation biopsies limits its value to…
2017 American Transplant Congress
Contribution of γδ T-Cell Subsets and IL-17A Release to Ischemia Reperfusion Injury (IRI) and Kidney Allograft Rejection in Mice.
A. Thorenz,¹ S. Rong,¹ N. Völker,¹ R. Chen,¹ J. Bräsen,² H. Haller,¹ C. Klemann,³ F. Gueler.¹
¹Nephrology, Hannover Medical School, Hannover, Germany; ²Pathology, Hannover Medical School, Hannover, Germany; ³Pediatric Surgery, Hannover Medical School, Hannover, Germany
Ischemia reperfusion injury (IRI) contributes to acute allograft injury and to delayed graft function (DGF) which is a trigger for acute rejection after kidney transplantation…
2017 American Transplant Congress
Diagnostic Bronchoscopy in Kidney Transplant Recipients with Acute Respiratory Failure: Risk or Value?
D. Khadzhynov, J. Deissler, F. Halleck, L. Lehner, K. Budde, O. Staeck.
Nephrology, Charité Universitaetsmedizin, Berlin, Germany
Introduction:Few data evaluates the differential diagnostic value of bronchoalveolar lavages (FO-BAL) in kidney transplant recipients (KTR) with acute respiratory failure (ARF). We describe the results…
2017 American Transplant Congress
Alemtuzumab Induction Is Associated with a Lower Incidence of BK Virus Nephropathy Compared with IL2RA Induction.
A. Gueret-Wardle, S. Hassan, G. Lucisano, C. Roufosse, M. Willicombe, D. Taube.
Renal Medicine, West London Renal and Transplant Centre, London, United Kingdom
Introduction:BK polyoma virus associated nephropathy [BKVAN] is a major cause of allograft dysfunction and graft loss occurring in up to 10% of kidney allograft recipients…
2017 American Transplant Congress
Donor and Recipient Outcomes with Trans-Umbilical Laparoendoscopic Single-Site Donor Nephrectomy.
H. El Hennawy, A. Fahmy.
Surgery Department, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia
Introduction: Laparoendoscopic single-site donor nephrectomy (LESS-DN) emerged as an advancement to standard laparoscopic surgery with its advantage of using a single small incision concealed in…
2017 American Transplant Congress
The Evolution of Hepatitis B Surface Antibody (Anti-HBs) Titer of the Kidney Transplant Recipients: A 5-Year Experience Guideline for the Optimal Maintaining Immunization.
W. Chancharoenthana, A. Leelahavanichkul, S. Wattanatorn, Y. Avihingsanon, K. Praditpornsilpa, N. Townamchai.
Division of Nephrology, Department of Medicine, Chulalongkorn University, Bangkok, Thailand
Background: Immunization against hepatitis B virus (HBV) in kidney transplantation (KT) recipients is recommended as KDIGO guideline. Although hepatitis B surface antibody (anti-HBs) titer of…